Find policies, billing codes, payers, states, and providers
CPT 54200: Penile Injection for Peyronie Disease
CPT code 54200 designates a penile injection procedure used to treat Peyronie disease by delivering medication into the external penis to reduce plaque-related curvature. This code matters nationally because Peyronie disease can cause pain, functional impairment, and quality-of-life effects; injectable therapies represent a common, minimally invasive management option and drive outpatient urology procedure volumes. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what CPT code 54200 represents clinically, where the service is typically provided, and how it fits into urologic outpatient care. The publication summarizes common billing contexts and expected places of service for this procedure, highlights typical modifiers and coding considerations (Data not available in the input for payer-specific rates and diagnosis mappings), and provides clinical context about why injectable therapy is used for Peyronie disease. This national overview is intended to orient clinicians, billing staff, and policy analysts to the code’s clinical role and billing classification without state-specific details.
Customize your policy alerts
Sign up for cpt 54200 policy alerts
Get alerted when payer policies referencing 54200 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 54200 describes an injection of medication into the external structures of the penis performed for treatment of Peyronie disease, a condition characterized by abnormal curvature of the erect penis. This procedure is a penile injection therapy intended to address plaque-related curvature and improve penile form and function.
-
Service type: Office-based or clinic procedural injection
-
Typical site of service: Urology clinic or outpatient ambulatory care setting